Sélection 2023

Selene E. Di Carlo et al.
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Nature Immunology 2023, vol. 24, issue 11
doi: 10.1038/s41590-023-01642-7

Selam Mihreteab et al.
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
New England Journal of Medicine 2023, vol. 389, issue 13
doi: 10.1056/nejmoa2210956

M

Wenwen Gao et al.
Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity
Nature Metabolism 2023, vol. 5, issue 10
doi: 10.1038/s42255-023-00889-6

M

Domenico Iuso et al.
Nucleoside diphosphate kinases 1 and 2 regulate a protective liver response to a high-fat diet
Science Advances 2023, vol. 9, issue 36
doi: 10.1126/sciadv.adh0140

M

Salomé Decombis et al.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
Blood 2023, vol. 142, issue 18
doi: 10.1182/blood.2023020211

Marion Thibaudin et al.
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
Nature Medicine 2023, vol. 29, issue 8
doi: 10.1038/s41591-023-02497-z

M

Yujiao Zhang et al.
Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-40216-x

M

Cyril Esnault et al.
G4access identifies G-quadruplexes and their associations with open chromatin and imprinting control regions
Nature Genetics 2023, vol. 55, issue 8
doi: 10.1038/s41588-023-01437-4

M

Mathias Boulanger et al.
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias
Nucleic Acids Research 2023, vol. 51, issue 16
doi: 10.1093/nar/gkad581

Manuel Rodrigues et al.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-39383-8